Skip to main content
Signal8

Scheessele William John

SEC insider (Form 3/4/5 filer). CIK 0001879378. Chief Commercial Officer at Humacyte, Inc. (HUMA). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 14, 2025. Located in DURHAM, NC.

Companies Scheessele William John has filed insider reports for

  • Humacyte, Inc. (HUMA): Officer, Chief Commercial Officer
Scheessele William John profile photo

Scheessele William John

CIK: 0001879378

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Humacyte, Inc. logo
HUMA

Humacyte, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Apr 14, 2025
    Purchase
    Direct
    6.5K shares at avg. $1.54$10K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jan 21, 2025
    Award

    Stock Options (right to buy)

    Direct
    283.1K shares-

1-2 of 2